Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tubulin alpha pseudogene 12 (TUBAP12) is a pseudogene classified in the tubulin alpha gene family. Unlike functional alpha-tubulin genes, TUBAP12 does not produce a protein product and lacks a characterized biological or pharmacological role. Pseudogenes such as TUBAP12 can arise through gene duplication or retrotransposition events and are generally considered non-functional remnants of evolution. In scientific databases, TUBAP12 is specifically annotated as a pseudogene, and there is no evidence for its translation, function, or relevance as a therapeutic target. This makes it notably distinct from functional members of the tubulin alpha family, such as TUBA1A or TUBA1B, which code for proteins critical to cytoskeleton biology and neurodevelopment[4][5].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tubulin alpha pseudogene 12 (TUBAP12).